258 related articles for article (PubMed ID: 21639679)
1. Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project.
Mandenius CF; Andersson TB; Alves PM; Batzl-Hartmann C; Björquist P; Carrondo MJ; Chesne C; Coecke S; Edsbagge J; Fredriksson JM; Gerlach JC; Heinzle E; Ingelman-Sundberg M; Johansson I; Küppers-Munther B; Müller-Vieira U; Noor F; Zeilinger K
Altern Lab Anim; 2011 May; 39(2):147-71. PubMed ID: 21639679
[TBL] [Abstract][Full Text] [Related]
2. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
3. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
[TBL] [Abstract][Full Text] [Related]
4. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
Donato MT; Tolosa L
Differentiation; 2019; 106():15-22. PubMed ID: 30844688
[TBL] [Abstract][Full Text] [Related]
5. Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes.
Kim JH; Wang M; Lee J; Park HJ; Han C; Hong HS; Kim JS; An GH; Park K; Park HK; Zhu SF; Sun XB; Kim JH; Woo DH
Cell Biol Toxicol; 2018 Feb; 34(1):51-64. PubMed ID: 28382404
[TBL] [Abstract][Full Text] [Related]
6. Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor.
Sivertsson L; Synnergren J; Jensen J; Björquist P; Ingelman-Sundberg M
Stem Cells Dev; 2013 Feb; 22(4):581-94. PubMed ID: 22970843
[TBL] [Abstract][Full Text] [Related]
7. Biohybrid Membrane Systems and Bioreactors as Tools for In Vitro Drug Testing.
Salerno S; Bartolo L
Curr Pharm Des; 2017; 23(2):319-327. PubMed ID: 27784240
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hepatotoxicity of chemicals using hepatic progenitor and hepatocyte-like cells derived from mouse embryonic stem cells: effect of chemicals on ESC-derived hepatocyte differentiation.
Kang SJ; Jeong SH; Kim EJ; Cho JH; Park YI; Park SW; Shin HS; Son SW; Kang HG
Cell Biol Toxicol; 2013 Feb; 29(1):1-11. PubMed ID: 23108452
[TBL] [Abstract][Full Text] [Related]
9. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
[TBL] [Abstract][Full Text] [Related]
10. Technological advancements for the development of stem cell-based models for hepatotoxicity testing.
Natale A; Vanmol K; Arslan A; Van Vlierberghe S; Dubruel P; Van Erps J; Thienpont H; Buzgo M; Boeckmans J; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
Arch Toxicol; 2019 Jul; 93(7):1789-1805. PubMed ID: 31037322
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
[TBL] [Abstract][Full Text] [Related]
12. Stem cell models for drug discovery and toxicology studies.
Liu W; Deng Y; Liu Y; Gong W; Deng W
J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of potential hepatotoxicity induced by drugs.
Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
[TBL] [Abstract][Full Text] [Related]
14. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
15. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
Greenhough S; Medine CN; Hay DC
Toxicology; 2010 Dec; 278(3):250-5. PubMed ID: 20674645
[TBL] [Abstract][Full Text] [Related]
17. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
18. The way forward in reproductive/developmental toxicity testing.
Spielmann H
Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
[TBL] [Abstract][Full Text] [Related]
19. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
[TBL] [Abstract][Full Text] [Related]
20. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?
Kia R; Sison RL; Heslop J; Kitteringham NR; Hanley N; Mills JS; Park BK; Goldring CE
Br J Clin Pharmacol; 2013 Apr; 75(4):885-96. PubMed ID: 22703588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
